Source recordFED

Molnar, Amber

Federal grants & contributions· Canadian Institutes of Health Research· FY2017· $26,250· ON

Description

The Association of Beta Blocker use with Mortality in Patients with Heart Failure and Severe Chronic Kidney Disease

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$26,250$0Original · 2016-07-01 (start date) · total $26,250
  • #02016-07-01$26,250
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2016-07-01(start date)$26,250—The Association of Beta Blocker use with Mortality in Patients with Heart Failure and Severe Chronic Kidney Di…

Related records · 1

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2023-2024-Q3-00702Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$1,682,998FY2024

Cite as: Glassbox record view · Federal grants & contributions · 236-2016-2017-Q2-00030 · retrieved 2026-11-15.